Drug Type Small molecule drug |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HER2 Positive Breast Cancer | Phase 1 | US | - | |
Prostatic Cancer | Preclinical | US | 11 Aug 2023 | |
Triple Negative Breast Cancer | Preclinical | US | 11 Aug 2023 |